
UNH
UnitedHealth Group Incorporated · NYSE
$512.60+0.97%
9 Sep close- Market cap
- $472B
- Sector
- Health care
Cash flow
Operating, investing and financing cash flows
Loading

| Quarter | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | TTM | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | 30 Sep 23 | 31 Dec 23 | 31 Mar 24 | 30 Jun 24 | 30 Sep 24 | 31 Dec 24 | 31 Mar 25 | 30 Jun 25 | 30 Sep 25 | 31 Dec 25 | 31 Mar 26 | 30 Jun 26 | 30 Jun 26 | Each line by period |
| Net income | $4.4B | $4.6B | $4.3B | $4.4B | $4.5B | $4.8B | $4.5B | $4.7B | $4.8B | $5.0B | $4.9B | $5.0B | $19.8B | |
| Depreciation and amortisation | $1.0B | $1.1B | $1.1B | $1.1B | $1.1B | $1.2B | $1.1B | $1.2B | $1.2B | $1.3B | $1.2B | $1.2B | $4.9B | |
| Share-based compensation | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $1.3B | |
| Working capital and other | −$0.7B | −$0.8B | −$0.4B | −$0.4B | −$0.4B | −$0.5B | −$0.4B | −$0.4B | −$0.4B | −$0.5B | $0 | $10M | −$0.9B | |
| Cash from operating activities | $5.0B | $5.3B | $5.2B | $5.4B | $5.5B | $5.8B | $5.6B | $5.8B | $5.8B | $6.2B | $6.4B | $6.6B | $25.1B | |
| Capital expenditure | −$0.7B | −$0.8B | −$0.8B | −$0.8B | −$0.8B | −$0.8B | −$0.8B | −$0.8B | −$0.9B | −$0.9B | −$0.9B | −$0.9B | −$3.5B | |
| Acquisitions, net of cash acquired | −$3.1B | −$3.3B | −$2.3B | −$2.4B | −$2.4B | −$2.5B | −$1.6B | −$1.6B | −$1.6B | −$1.7B | −$3.3B | −$3.4B | −$10.1B | |
| Buy-backs, dividends and other returns | −$3.4B | −$3.6B | −$3.4B | −$3.5B | −$3.5B | −$3.8B | −$3.6B | −$3.7B | −$3.7B | −$4.0B | −$3.9B | −$4.0B | −$15.5B | |
| Debt issued, net of repayments | $1.6B | $1.7B | $1.6B | $1.6B | $1.6B | $1.7B | $1.6B | $1.6B | $1.6B | $1.7B | $1.6B | $1.6B | $6.5B | |
| Other investing and financing, net | $1.0B | $1.1B | −$0.1B | −$30M | −$0.1B | −$20M | −$0.8B | −$0.9B | −$0.9B | −$0.9B | $0.4B | $0.4B | −$1.1B | |
| Net change in cash and investments | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $1.3B | |
| Free cash flow | $4.2B | $4.5B | $4.5B | $4.6B | $4.7B | $4.9B | $4.8B | $4.9B | $5.0B | $5.3B | $5.6B | $5.7B | $21.6B | |
| Derived metrics | ||||||||||||||
| Free cash flow as a share of revenue | 4.6% | 4.5% | 4.7% | 4.7% | 4.7% | 4.7% | 4.7% | 4.7% | 4.7% | 4.6% | 5.1% | 5.1% | 4.9% | |
| Capital expenditure as a share of revenue | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | 0.8% | |
Billions of dollars. Outflows are negative. Capital expenditure as a share of revenue is on its magnitude, as it is normally quoted.